Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.
CA 02455669 2004-O1-22
METHOD AND TEST STRIP FOR
DETERMINING GLUCOSE IN BLOOD
[0001] The instant invention related to a method and test
strips for determining the amount of .an analyte within a sam-
ple. More particularly, this invention relates to a method
for determining the amount of glucose in blood, and to sample
strips useful in such a method.
Background of the Invention
[0002] It has become increasingly important to medical sci-
ence to be able to quantify the chemical and biochemical com-
ponents of a wide variety of fluids, particularly colored
aqueous~biological fluids such as whole blood and urine, and
biological derivatives such as serum and plasma. Such ability
is important in testing for exposure to hazardous materials,
intoxicants, and therapeutic drugs, a.nd in diagnostics. In
some applications, it is important for a lay person to be able
to perform the test outside a laboratory environment, with
rapid and accurate results. For example, diabetics must test
samples of their own blood for glucose several times a day to
moderate their diet and medication. The test results must be
both rapidly available and accurate.
[0003] Test kits for the determination of glucose in blood
are well known in the art. Such test often involve a test
strip impregnated with one or more chemicals that react in the
presence of glucose to cause a color change in the test strip.
The color change in the test strip is measured by known opti-
cal detection methods. While a change in either absorption,
transmittance, or reflectance of a sample can be measured,
typically for glucose determinations the change in refl-ectance
is measured. Generally, as the glucose concentration in a
sample increases; the strip will generate more color and be-
CA 02455669 2004-O1-22
come darker. A darker test strip will give off less reflec-
tance, such that a lower reflectance level will indicate more
glucose in the sample.
[0004] The presence of red blood cells in a blood sample
can interfere with the reflectance reading by reflecting light
back to the detector at the same wavelength as the glucose
reading is made, or by blocking the transmission of light so
that all the color developed in response to glucose cannot be
read, or by scattering the light. Thus some test kits require
that the red blood cells be filtered out of the sample or
lysed prior to applying the sample to a test strip.
[0005] One series of patents relating to the colorimetric
determination of glucose in blood includes U.S. 4,935,346,
U.S. 5,049,487, U.S. 5,049,394, U.S. 5,179,005, arid U.S.
5,304,468, all assigned to Lifescan, Inc. of Mountain View,
California, and all incorporated herein by reference in their
entireties. The method disclosed therein involves taking a
reflectance reading from one surface of an inert two-sided po-
rous matrix. The matrix is impregnated with a reagent that
will interact with the analyte to produce a light-absorbing
reaction product when the fluid being analyzed is applied to
the first surface and migrates through the matrix to the sec-
ond surface. Reflectance measurements of the second surface
are made at two separate wavelengths in order to compensate
for interference from hematocrit variation, and for variation
caused by the chromatography of the color generated in re-
sponse to glucose at a given concentration. A timing circuit
is triggered by an initial decrease in reflectance caused by
the wetting of the second surface by the fluid which passes
through the inert matrix. The method does not require the
separation of red bload cells from serum or plasma.
CA 02455669 2004-O1-22
3
[0006] U.S. 5,484,708 assigned to Boehringer Mannheim GmbH,
entitled "Method for the Colorimetric Determination of an Ana-
lyte with a PQQ-Dependent Dehydrogenase'° discloses a method
for the colorimetric determination of an analyte by means of
enzymatic oxidation with a PQQ-dependent dehydrogenase in the
presence of an electron acceptor from the group of the elec-
tron-rich aromatic r~itroso compounds by enzymatic reduction of
the nitroso compound to wn imino compound and detection of the
imino compound by color formation.
[0007] U.S. 5,789,255, also assigned to Lifescan, Inc. and
incorporated herein by ,reference in its entirety, is entitled
"Blood Glucose Strip having Reduced Sensitivity to Hemato-
crit." This patent discloses a reagent strip comprising an
anisotropic membrane having a sample side with relatively
large pores and a testing side with relatively small pores. A
test sample is applied to the sample side and passes through
the membrane toward the testing sidE:, while the relatively
large red blood cells are filtered out of the blood sample.
The membrane is irnpre.gnated with a testing agent comprising a
component that reacts with glucose and oxygen to create hydro-
gen peroxide, a color indicator that reacts with the hydrogen
peroxide, and an acrylic acid polymer that reduces the effect
of the red blood cells on the glucose concentration measure-
ment . It is believed that the acrylic acid polymers used are
of relatively high molecular weight, a.nd affect the viscosity
and flow of the sample.
[0008] In such prior art methods of testing for glucose us-
ing optical detection methods, it is recognized that the de-
tection system must adjust for the opacity of a reflective
surface. It is known that a reaction surface that is more
opaque will be less sensitive to the presence of red blood
cells. In some such methods, the opacity is adjusted by the
CA 02455669 2004-O1-22
.
use of scattering centers incorporated into the reflective
surface of the matrix. Such known scattering centers include
titanium dioxide, diatomaceous earth, powdered metals, miner-
als, and various combinations of these and other materials.
Other factors known to affect opacity include pore size, pore
structure, and the surface area of the supporting media.
[0009] It is one object of the invention to provide a
method for testing a sample of a fluid that does not require
the separation or lysing of red blood cells from a whole blood
sample.
[0010] It is a further object of the invention to provide
such a method that can be done with a very small sample of
fluid, typically less than one microliter.
[0011] It is still another object of the invention to pro-
vide such a test method that is not sensitive to variations of
hematocrit from sample to sample.
[0012] It is yet another object of the invention to provide
a test strip suitable for use with the inventive method.
Summary Of The Invention
[0013] The foregoing objects are met by the invention
herein, wherein a method of determining glucose in a sample
includes the use of a two-sided test strip in which one or
more polymers are used to change the opacity of the surface
being optically read. In a preferred embodiment, the polymer
also will control the chromatography of the reaction product
by maintaining the testing reagents at the reaction site
and/or the read site. In accordance with the invention, a
method for determining glucose concentration in a sample of
CA 02455669 2004-O1-22
whole blood comprises (a) providing a test strip having a sam-
ple side and a reaction side, the test strip being adapted to
accept the sample on the sample side and pass it toward the
reaction side, said test strip supporting a testing reagent,
said testing reagent comprising a color indicator system that
changes color to indicate the presence of glucose in the sam-
ple, said test strip further having a polymer applied thereto
at least on the reaction side, said polymer increasing the
opacity of the reaction side of the test strip; (b) applying
the blood sample to the sample side of the test strip; and,
(c) measuring the change in color of the reaction side to de-
termine the glucose concentration in the blood.
[0014] The test strip preferably comprises a porous mem-
brane made from a material selected from the group consisting
of polyethersulfone and modified polyethersulfones. The one
or more polymers applies to the porous membrane are preferably
selected from the group consisting of acrylic latex polymers
and polystyrene sodium sulfate.
Brief Description of the Figures
[0015] The instant invention will be more readily under-
stood by reference to the figures, wherein
[0016] Fig. 1A is a perspective drawing of a test strip
made in accordance with the instant invention;
[0017] Fig. 1B is an exploded view of an alternative em-
bodiment of a test strip made in accordance with the inven-
tion:
CA 02455669 2004-O1-22
6
[0018] Fig. 1C is an exploded view of another alternative
embodiment of a test strip suitable for use with the instant
invention.
[0019] Fig. 2 is a graph of the results achieved with large
and small pore size membranes in the detection f glucose in
both aqueous solutions and whole blood using test strips pre-
pared in accordance with the invention;.
[0020] Fig. 3 is a graph showing the response of capillary
fill format test strips in accordance with the instant inven-
tion for different concentrations of glucose in both aqueous
solution and whole blood.
[0021] Fig. 4 is a graph showing the response at different
endpoints of test strips made in accordance with the invention
in which the reactive chemistry is applied to the test strip
,as a stripe.
Detailed Description of the Invention
[0022] The method of the instant invention comprises the
determination of glucose in a sample by the known steps of
placing the sample on a first side of a test strip, allowing
any glucose in the sample to react with reagents impregnated
in the test strip, and taking an optical measurement of the
opposite side of the test strip after the sample has passed
through the test strip. In accordance with the invention, the
test strip is provided with one or more polymers-that alter
the opacity of the test strip in a manner that makes the glu-
cose determination less sensitive to the presence of red blood
cells in the sample. In each of Figs. 1A-C, the thickness of
the layers is shown for clarity of illustration and is not in-
CA 02455669 2004-O1-22
3 7
tended to be representative of the actual thicknesses of the-
layers in a test strip product.
{0023] Fig. 1A is a perspective view of a test strip 10
suitable for use in the method of the instant invention. As
illustrated in the Fig. 1A, test strip 10 comprises a handle
13 to which is bonded a porous membrane 11. Because the
method of the instant invention does not require filtration of
red blood cells from the sample prior to making the optical
measurement, the pore structure can be constant in the x, y,
and z directions in the test strip, although membranes having
an anisotropic pore size gradient also can be used. The po-
rous membrane 11 has .a first side 12, also known as the test
side or the sample side, and a second side 14, also known as
the reaction side. A sample is deposited through hole 17 in
handle 13 onto test side 12 of porous membrane 11. The sample
passes through the pores of the membrane to reaction side 14
of the porous membrane 11. An optical measurement of reaction
side l4, such as reflectance; is then correlated with glucose
concentration to determine the amount of glucose present in
the sample.
[0024] In accordance with the invention, reaction side 14
of porous membrane 11 is treated with a testing reagent compo-
sition 16 comprising a color indicator system that changes
color to indicate the presence of glu<:ose in the sample, the
reagent composition 16 further comprising a polymer that af-
fects the opacity of reaction side 14 of porous membrane 1l.
The reagent composition 16 including the polymer can be ap-
plied to the test strip by methods such as dipping, coating,
and striping. In the embodiment illustrated in Fig. 1A, the
composition is applied as coating l6 over reaction side 14 of
test strip 10. In another embodiment, the composition will be
first applied to side 12 such as by dipping and allowed to
CA 02455669 2004-O1-22
8
pass through the strip to reconstitute on side 14. Those
skilled in the art will be able to optimize the parameters of
the composition application processes to achieve the desired
composition layer 16, including the polymer. The polymer in
the reagent composition can also affect the chromatography of
the analyte through the test strip. An optically clear window
18 can be applied to composition 16 by known methods, includ-
ing laminating or use of a pressure-sensitive adhesive ~.9.
Window 18 can be made of polyester or any other optically
suitable material.
[0025] Fig. 1B illustrates an alternative embodiment of a
test strip made in accordance with the invention. In this em-
bodiment, test strip 20 comprises handle 13 from which has
been cut a hold 15. Disc 25 comprises porous membrane 21 hav-
ing a sample side 22 and a reaction side 24. Applied to reac-
tion side 24 is a testing reagent composition 25 comprising a
color indicator system that changes color to indicate the
presence of glucose in the sample, and. a polymer that changes
the opacity of the reaction side 24 of porous membrane 21.
Disc 25 is fitted into hole 15, and an optically clear window
28 is applied over disc 25 and the portion of handle 13 in
which it is received. It may be seen that this embodiment re-
quires less of the treated porous membrane material than the
embodiment of Fig . 1A, or the prior art devices shown and de-
scribed in the aforementioned prior art patents such as U.S.
5,789,255. It will be appreciated that disc 25 can be in the
form of ribbons or other suitable geometric configurations.
[0026] Fig. 1C illustrates yet another alternative embodi-
ment of a test strip suitable for use with the instant inven-
tion. In this embodiment, test strip 30 comprises handle 33.
Ribbon 35 comprises porous membrane 31 having a sample side 32
and a reaction side 34. The porous membrane 31 is provided on
CA 02455669 2004-O1-22
3 9
reaction side 34 with a composition 36 comprising a testing
reagent comprising a color indicator system that changes color
to indicate the presence of glucose in the sample and a poly-
mer that changes the opacity of the reaction side 34 of porous
membrane 31. A spacer 37 having a capillary inlet 38 is ap-
plied over a portion of strip 33 and ribbon 35 with adhesive,
such that capillary inlet 38 is disposed over a portion of
ribbon 35. A lid is optionally disposed over spacer 37 to
protect the instrument from contamination. A window is dis-
posed on the oppositd side of the test strip.
[0027] In each of the embodiments illustrated, the porous
membrane supports a reagent composition that reacts in the
presence of glucose to produce a reaction product that can be
measured with an optical detector to allow quantitative deter-
mination of glucose. The chemistry of the reaction can be ei-
ther reductive or oxidative: A reductive chemistry system
suitable for use with the instant invention can be, for exam-
ple, either a PQQ-GDH or a NAD-dependent GDH system. A hexo-
kinase reductive system also can be used, as can a glucose
oxidase oxidative system. For the NAD dependent GDH system,
appropriate mediators include, without limitation, those dis-
closed in U:S. 5,520,786. Such mediators include compounds
selected from the group of substituted or unsubstituted 3-
phenylimino-3H-phenathiazines and 3-phenylimino-3H-
phenoxazines. Appropriate indicators include, without limita-
tion, WST-4, as well as the general classes of 2-thiazolyl
tetrazolium salt compounds disclosed in U.S. 5,126,275 and
U.S. 5,322,680. Each of the foregoing patents is assigned to
the present assignee and is incorporated herein by reference
in its entirety.
[0028] In the course of this work, it has been found that
the mediators reported in LI.S. 5,520,786 as being useful in an
CA 02455669 2004-O1-22
' 10
electrode-based NAD dependent GDH system can also be used in
an optically-based NAD dependent GDH system as described imme-
diately above, as well as an optically based PQQ-GDH reductive
system. This result is surprising for at least two reasons.
First, mediators can be specific for different enzymes. Not
all mediators that work in NAD-GDH systems necessarily work as
well in PQQ-GDH systems. Second, the mediators disclosed in
U:S. 5,520,786 are colored. While this is not problematic in
an electrode-based system such 'as disclosed in U.S. 5,520,786,
one would expect that these mediators could not be used in an
optically based system such as disclosed herein. Applicant
has found, however, that because these mediators change from
colored to colorless during the course of the reaction, they
do not interfere with the measurement at the final endpoint.
One skilled in the art could envision that though it is gener-
ally preferred to measure color generation, color disappear-
ance could also be measured, although the former typically
gives better test precision. Thus it is within the scope of
this invention to use a PQQ-GDH reductive system with a.media-
for as disclosed in U.S. 5,520,786, and with the additional
one or more polymers to control opacity as disclosed herein.
Suitable indicators for such systems include a tetrazolium in-
dicator such as WST-4, available from Dojindo Laboratories, or
a tetrazolium salt indicator such as those disclosed in U.S.
5,126,275 and U.S. 5,322,680 as discussed above.
[0029] Porous membrane materials suitable for use in the
method of the instant invention include commercially available
materials such as porous polyethersulfone membranes such as
those sold under the brand name Supor and Presense and avail-
able from Pall Corporation; and modified porous polyethersul-
fone membranes such as those sold under the brand name Preda-
tor and available from Pall Corporation. Those skilled in the
CA 02455669 2004-O1-22
11
art will recognize that other porous membranes will be suited
to use as membranes in test strips of the instant invention.
[0030] Materials suitable for use as the polymer applied to
the membrane include, for example, acrylic latex polymers such
as those sold.under the brand name UCAR and available from Un-
ion Carbide, polystyrene sodium sulfate polymers such as those
available. from Polysciences, Inc., and combinations thereof.
EXAMPLE 1
[0031] The dose responses to glucose in both aqueous solu-
tion and whole blood for test strips prepared in accordance
with the instant invention were determined for both small-pore
and large-pore test strip membranes. The porous membranes
used were Supor brand polyethersulfone membranes purchased
from Pall Corporation, and having isotropic pore sizes of 0.2
microns and 5.0 microns. Each porou s membrane was treated
with reagent by dipping the smooth reaction side of the mem-
brane in the composition set forth in Table 1.
Table 1.
Reagent Final cone.
0.4M Sodium HEPES 0.2M
WST-4 40 mM
40g PSSA, mw=70k 5s
UCAR 455 (45~ solids) 10.000
NAD 10 mM
Diaphorase 1016 U/mL
GDH (glucose dehydrogenase) 1900 U/mL
Mutarotase 3370 U/mL
Adj ust pH to 7 . 3-7 : 5 with NaOl~i -
[0032] The membranes were dried at ~0-50°C. for at least 5
minutes in a high air flow oven. The membranes were cut into
discs and fitted into strips as described above in connection
with the embodiment of Fig: 1B. A clear polyester film window
CA 02455669 2004-O1-22
12
was applied to the coated reaction side using Arcare 7843
pressure sensitive adhesive available from Adhesives Research.
The test strips were oriented with the reaction side facing
down. Test samples of 500 nanoliters of either aqueous glu-
cose solution or hole blood spiked with glucose were then ap-
plied to the rough sample side of each disc in the test strip.
The glucose solutions were buffered to pH 7.5 using 0.15M Na
HEPES. The glucose concentrations in the aqueous and whole
blood samples were at 0 mg/dL, 50 mg,~dL, 250 mg/dL, and 600
mg/dL. The whole blood samples were spiked to the indicated
level and measured as plasma glucose using a Yellow Springs
Co., Inc. model 2300 STAT Plus glucose detector. Two repli-
cates were run of each sample solution on each sample test
strip. The reflectance of each test strip at 680 nm was meas-
ured at the clear polyester film window using the apparatus
described in co-pending patent application S.N. 60/373,583,
filed April 19, 2002. This instrument uses a small-read-area
reflectance read head of about 0.030 inches diameter. The
measured reflectance values R were converted to a linearizing
function K/S by the formula K/S = (1-R)2/2R. As shown in Fig.
2, the measured reflectance for each level of glucose was sub-
stantially the same for both aqueous solutions and for whole
blood, and for the different pore sizes of the test discs, in-
dicating that for test strips made in accordance with the in-
vention the dose response was substantial independent of both
membrane pore size and whether or not whole blood was present
in the sample.
EXAMPLE 2
[0033 This example demonstrates the feasibility of the
dipped reagent membrane technique when the samples are applied
using a lateral flow, capillary format as illustrated and dis-
cussed in connection with Fig. 1C, rather than the flow
CA 02455669 2004-O1-22
' ~ 13
through technique used in Example 2 above. Samples of 0.8 mi-
cron pore size polyethersulfone membrane sold under the trade
name "Presense" from Pall Corporation were treated as de-
scribed in Example 1. Ribbons of the treated membrane were
mounted on capillary flow test strips as illustrated in Fig.
1C. Each test strip had applied to it a 600-800 nanoliter
sample of either aqueous glucose solution or glucose in 400
hematocrit whole blood. The concentrations of glucose in the
aqueous test samples were 0, 50, 100, 250, and 500 mg/dL. The
concentrations of glucose in the whole blood samples were 0,
50, 100, 250, 400 and 600 mgldL, converted to plasma values.
[0034] Reflectance was measured at 680 nm at a 30-second
endpoint using the instrument described in Example l, and the
values were linearized as described above. The results are
illustrated in Fig. 3. It may be seen that the results ob-
tained for the corresponding aqueous .and whole blood samples
each produced linear functions having substantially the same
slope and intercept, indicating that the reflectance values
obtained with the test strips of the instant invention were
independent of the hematocrit of the whole blood samples.
EXAMPLE 3
[0035] Test strips were prepared using 0.8 micron pore size
polyethersulfone porous membrane materials sold under the
brand name Presense by Pali Corporation. The reagent composi-
tion used was that described in Table 1. The reagent composi-
tion was applied by striping onto the reaction side of the po-
rous membrane rather than by dipping. The test strips were
then provided with clear polyester windows secured by Arcare
7843 pressure-sensitive adhesive, and were laminated with rib-
bons of reagent, all as described in Example 1 above. The
test strips were oriented with the reaction side facing down.
CA 02455669 2004-O1-22
14
Test samples of 500 nanoliters of whole blood spiked with glu-
rose were then applied to the rough sample side of each test
strip. The glucose whole blood samples were at 0 mg/dL, 50
mg/dL, 100 mg/dL 200 mg/dL, 400 mg/dL, and 600 mg/dL measured
as plasma glucose using a Yellow Springs Instrument detector.
Two replicates were run of each sample solution on each sample
test strip.
[0036] The reflectance of each test strip was measured us-
ing the instrument described in Example 1 above at 680 nm us-
ing a small-read-area reflectance read head of about 0.030
inches diameter. The measured reflectance values R were con-
verted to a linearizing function K/S by the formula K/S - (1-
R)2/2R. Reflectance measurements were taken at l0, 20, 30 and
40 seconds. The results are illustrated in Fig. 4. It may be
seen that the measured reflectance was proportionate to the
glucose dose for the whole blood samples and a rapid and sta-
ble endpoint was achieved over the full glucose range, indi-
cating that striping can produce an effective test strip in
accordance with the invention.
EXAMPLE 4
[0037] This example demonstrates the utility of the media-
tors reported in U.S. 5,520,786 in an optically based PQQ-GDH
reductive system. Reagent was prepared as follows:
Table 2.
Reagent Final conc.
0.4M Sodium HEPES 0.2M
WST-r 40 mM
40% PSSA, mw=70k 5%
UCAR 455 (45% solids) 10.00%
PQQ-GDH 1245 U/mL
3-(3,5-dicarboxyphenylimino- 6 mM
3H-phenothiazine
Adjust pH to 7.3-7.5 with NaOH -
CA 02455669 2004-O1-22
[0038] Approximately 1 microliter aliquots of the reagent
mixture were placed onto pre-cut strips of 0.8 micron polyeth-
ersulfone Presence membrane and 0.2 and 5.0 micron polyether-
sulfone Supor membranes. After air drying at room tempera-
ture, 50 nL aliquots of 0, 50, 200 mg/dL aqueous glucose sam-
ples were added. Changes in color, the uniformity of color,
and the speed of color changes were observed. Visual dose re-
sponses were observed for the glucose samples. Aliquots of a
similar formulation with 0.1o Silwet L--7600 surfactant and fi-
nal formulation pH of approximately 7:0 were also placed in a
micro-cuvette (e.g. small volume, 50 micron path length) and a
dose response. with the addition of 0 to 500 mgldL whole blood
glucose was observed. A range of approximately 25 to 5 per-
cent reflectance was observed. These results indicate that 3-
(3,5-dicarbosypheylimino)-3H-phenothiazine can be an effective
mediator for the PQQ-GDH determination of glucose in both
aqueous and whole blood samples.
EXAMPLE 5
[0039] This example demonstrates the feasibility of using a
tetrazolium salt indicator such as those disclosed in U.S.
5,126,275 and U.S. 5,322,680 in a NAD dependent system in the
context of this invention. Reagent was prepared as described
in Table 1 of Example 1 above except that 40 mM of 2-(4-
difluoromethyl-5-chlorothiazol-2-yl)-3-[2-(3-trimethylammonio-
propoxy) phenyl]-5-(3,4-methylenedioxyphenyl) tetrazolium di-
methylsulfonate tetrazolium salt indicator was substituted for
the WST-4 tetrazolium salt. The reagent mix was used to coat
the smooth side of 0.8 micron polyeth~ersulfone Presence mem-
brane and then assembled into capillary fill formats. A dose
response to 0 to 600 mg/dL whole blood glucose was demon=
CA 02455669 2004-O1-22
16
strated with a range of approximately 30 to 10 percent reflec-
tance.
[0040] It will be appreciated that the inventive method and
test strips disclosed herein offer significant advantages over
prior art glucose determination systems. Such prior art glu-
cose determination systems typically require optical readings
of a sample at two different wavelengths to correct for the
interference introduced by the red blood cells (hematocrit) in
the sample. The test strips provide results that are inde-
pendent of the pore size of the membrane, and substantially
independent of the hematocrit of the sample. Since the system
is substantially independent of hematocrit, there is no need
to measure reflectance at two different wavelengths and apply
a correction factor. This means that the optical measurement
device used with the system of the instant invention can be
much simpler and less expensive than prior art systems, be-
cause it will require only one set of optics instead of two.
A system used in connection with the instant invention also
will not require a complicated algorithm to adjust for the he-
matocrit or chromatography. The invention also eliminates the
need for scattering centers used in prior art systems to ad-
just for the opacity of a reflective surface. Also, because
the sample does not need to undergo any procedure to separate
the red blood cells, a much smaller sample size can be used,
typically on the order of about 1 microliter or less. The
present invention has been described and exemplified above.
Those skilled in the art will recognize that other modifica-
tions and variations of the invention can be made without de-
parting from the spirit and scope hereof:
